Publication:
Expression of matrix metalloproteinases and endogenous inhibitors in abdominal aortic aneurysm and aortoiliac occlusive disease (syndrome leriche)

dc.contributor.authorVasic, N. (57201797483)
dc.contributor.authorGlumac, S. (33467624700)
dc.contributor.authorPejic, S. (6602841944)
dc.contributor.authorAmidzic, L.J. (57224488902)
dc.contributor.authorTadic Latinovic, L.J. (57201801229)
dc.contributor.authorDozic, B. (6507142704)
dc.contributor.authorHinic, S. (55208518100)
dc.contributor.authorMaksimovic, Z. (26537806600)
dc.date.accessioned2025-06-12T17:42:23Z
dc.date.available2025-06-12T17:42:23Z
dc.date.issued2017
dc.description.abstractMatrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) play a complex role in the pathogenesis of atherosclerosis. We compared (1) the histopathological findings in patients with abdominal aortic aneurysms (AAA) and aortoiliac occlusive disease (AOD); (2) the expression of MMP-2/MMP-9 and TIMP-1/TIMP-2 in aortic layers, inflammatory cells and smooth muscle cells (SMCs), aiming to identify the common underlying pathogenic mechanisms of the disease development. Samples were obtained from 30 patients with AAA and 30 with AOD. Aortic histology and immunohistochemistry were performed to evaluate inflammatory changes and MMP and TIMP expression. Thrombosis and ulceration were more frequent in AOD than in AAA. The MMP-9 expression was elevated in all aortic layers of AAA patients and in media/adventitia of AOD patients, mainly followed by lower expression of its inhibitor TIMP-1. Higher MMP-9 expression was also found in SMCs and macrophages of both AAA and AOD specimens, while higher TIMP-1/TIMP-2 were predominantly observed in the lymphocytes and macrophages of the aneurysm. These results showed that both conditions exhibited increased MMP-9 expression; however, the MMP expression pattern differed to some degree between the aneurysms and occlusive disease. The variations in molecular mechanisms underlying dilatative/stenosing disease warrant further investigation. © 2017 Charles University. All rights reserved.
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85046155361&partnerID=40&md5=8f6cf20f1a7eda63c008159fc4fd0bcc
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/7153
dc.subjectAbdominal aortic aneurysm
dc.subjectAortoiliac occlusive disease
dc.subjectMatrix metalloproteinases
dc.subjectSyndrome Leriche
dc.titleExpression of matrix metalloproteinases and endogenous inhibitors in abdominal aortic aneurysm and aortoiliac occlusive disease (syndrome leriche)
dspace.entity.typePublication

Files